AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comSEP 302 min read$SPCX

SPCX Stock Eyes 2-Month Winning Streak: Analyst Says SpaceX Could Double On 2,200 Annual Launches By 2030

SpaceX (SPCX) is scheduled for multiple launches, including a Falcon 9 and Falcon Heavy. Analysts forecast strong growth, with UBS estimating Q3 revenue of $13.8B and EBITDA of $7.5B, driven by AI and connectivity. Ratings include UBS 'Buy' ($210 target), CLSA 'Outperform' ($250), Morgan Stanley 'Overweight' ($300), and TD Cowen 'Buy' ($200). Retail sentiment on Stocktwits is bullish, with SPCX down 7% YTD.

Original reporting
finance.yahoo.com
Published Sep 30, 2026, 6:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 6:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
SPCX Stock Eyes 2-Month Winning Streak: Analyst Says SpaceX Could Double On 2,200 Annual Launches By 2030 — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$SPCXBullishMed
01

Why it matters

Analyst upgrades and high price targets are likely to attract momentum traders, creating short‑term buying pressure.

02

Market read

The consensus of high target prices and upgraded ratings signals a strong bullish catalyst for SPCX, likely prompting short‑term inflows.

03

What to watch

Potential propulsion reliability issues and regulatory hurdles for Starship could temper upside.

Relevance 7/10Novelty 7/10Timing: today

Background

SPCX is a publicly traded vehicle tracking SpaceX's launch, connectivity and AI businesses. Recent analyst coverage highlights rapid AI growth and a projected surge in launch cadence.

Company-level read

Ticker impact

$SPCXBullishHigh confidence
Context

Analyst houses UBS, CLSA, Morgan Stanley and TD Cowen issued new coverage with price targets ranging from $200 to $300 and upgraded ratings for SPCX.

Expected impact

likely upward pressure as traders price in the new target ranges and growth forecasts.

Evidence & confidence

Multiple independent analysts raised ratings and set targets implying 40‑100% upside, which typically drives buying interest.

Market effects

Sector

Positive outlook for the commercial space and satellite connectivity sector may lift peer stocks.

Regional

U.S. space‑tech equities could see broader buying pressure.

Global

Analyst optimism may influence global investors tracking AI‑linked space ventures.

Counterpoint

What could challenge this read

Skeptics may point to SpaceX's massive cash burn and capital‑intensive growth as risk factors.

Key entities

  • Analyst
    UBS

    Issued a Buy rating with a $210 target.

  • Analyst
    CLSA

    Initiated coverage with an Outperform rating and a $250 target.

  • Analyst
    Morgan Stanley

    Maintained Overweight rating with a $300 target.

  • Analyst
    TD Cowen

    Initiated coverage with a Buy rating and a $200 target.

Read at source← All news

Related articles

SEP 30
$ETNMed

Eaton, AMD and SpaceX: CNBC ‘Final Trades’ - Advanced Micro Devices (NASDAQ:AMD)

CNBC's 'Final Trades' featured picks from analysts: Joseph Terranova chose Eaton (ETN), supported by Wells Fargo's Overweight rating and $503 target. Stephanie Link mentioned SpaceX (SPCX), down 26% from highs, after its Starship launch. Jason Snipe picked AbbVie (ABBV) following FDA approval of Juvmo. Joshua Brown recommended AMD (AMD), with StoneX maintaining a Buy rating and $685 target. Shares of ETN, SPCX, ABBV, and AMD showed mixed price action.

benzinga.com2 min
SEP 30
$SPCXMedAI 8/10

SpaceX Still Trades Above Its IPO Price. Could Anthropic Do the Same?

Anthropic, parent of AI chatbot Claude, leaked its S-1 prospectus, revealing a $42 billion loss in 2023. The company is expected to IPO in November, raising around $100 billion at a $2 trillion valuation. SpaceX, which IPO'd earlier, has stabilized around its IPO price, offering a comparison for Anthropic's potential market performance.

aol.com3 min
SEP 29
$RKLBMedAI 8/10

Exclusive: Starship's Weak Spot Could Help Rocket Lab and Firefly - Rocket Lab (NASDAQ:RKLB), Firefly Aer

SpaceX's Starship reached orbit for the first time on its 14th test flight, deploying 26 Starlink V3 satellites. Despite an engine issue, the mission was cut short with a controlled splashdown. SpaceX aims for routine Starship flights later this year. Analysts suggest smaller launch companies like Rocket Lab (RKLB) and Firefly (FLY) may benefit due to Starship's limitations in serving smaller customers with specific orbit needs. SpaceX stock (SPCX) rose 1.97% following the launch.

benzinga.com2 min
SEP 29
$SPCXMedAI 8/10

SpaceX Rises 2% After Starship’s First Orbital Satellite Deployment; Rocket Lab Falls 3%, AST SpaceMobile Drops 3%

SpaceX stock rose 2% to $149.02 after its Starship vehicle reached orbit and deployed satellites for the first time, despite an engine fault. Rocket Lab and AST SpaceMobile stocks fell 3%, while the Procure Space ETF dropped 1%. Morgan Stanley, UBS, and TD Cowen maintained positive ratings on SpaceX, with price targets ranging from $200 to $300.

247wallst.com3 min
SEP 29
$SPCXMed

Musk: “First Orbital Flight Successful” as SpaceX’s Starship Reaches Orbit on Flight 14

SpaceX's Starship successfully reached orbit on its first attempt, deploying 26 Starlink V3 satellites. CEO Elon Musk confirmed the mission's success. SpaceX shares (SPCX) rose 0.97% to $146.88, but remain down 8.74% from their June IPO price. Starlink's Connectivity revenue grew 66% YoY to $4.29 billion, with over 12 million subscribers. The flight advances SpaceX's plans for larger, more capable satellites and reusability.

247wallst.com2 min